| |
 |
|
Class Information
Number: 424/142.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material > Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) > Human
Description: Subject matter involving a monoclonal antibody or fragment thereof derived from a human source or whose amino acid sequence is identical to that found in a human.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618631 |
Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs |
Nov. 17, 2009 |
| 7615214 |
Anti-human VEGF receptor Flt-1 monoclonal antibody |
Nov. 10, 2009 |
| 7615383 |
Methods for treating neuropathy by agonist anti-trk-C monoclonal antibodies |
Nov. 10, 2009 |
| 7615215 |
Anti-human VEGF receptor Flt-1 monoclonal antibody |
Nov. 10, 2009 |
| 7612179 |
antibodies binding to a C-terminal fragment of apoliopoprotein E |
Nov. 3, 2009 |
| 7611706 |
RG1 antibodies and uses thereof |
Nov. 3, 2009 |
| 7608263 |
RG1 antibodies and uses thereof |
Oct. 27, 2009 |
| 7608696 |
IBC-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
Oct. 27, 2009 |
| 7605238 |
Human CTLA-4 antibodies and their uses |
Oct. 20, 2009 |
| 7601353 |
Peptide-based passive immunization therapy for treatment of atherosclerosis |
Oct. 13, 2009 |
| 7601352 |
Monoclonal antibodies and antigen binding fragments thereof capable of binding TrkA and inhibiting the functional activation of TrkA |
Oct. 13, 2009 |
| 7601818 |
Human anti-NGF neutralizing antibodies as selective NGF pathway inhibitors |
Oct. 13, 2009 |
| 7597888 |
Glycoprotein VI and uses thereof |
Oct. 6, 2009 |
| 7597893 |
Human monoclonal antibody specific lipopolysaccharides (LPS) of serotype IATS 06 of Pseudomonas aeruginosa |
Oct. 6, 2009 |
| 7597886 |
Tumor necrosis factor-gamma |
Oct. 6, 2009 |
| 7597889 |
Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
Oct. 6, 2009 |
| 7595046 |
Treatment of cancer using anti-Apo-2 antibodies |
Sep. 29, 2009 |
| 7595048 |
Method for treatment of cancer by inhibiting the immunosuppressive signal induced by PD-1 |
Sep. 29, 2009 |
| 7588761 |
Human antibodies that bind human TNF.alpha. |
Sep. 15, 2009 |
| 7585504 |
High affinity antibodies against HMGB1 and methods of use thereof |
Sep. 8, 2009 |
| 7585500 |
Fully human monoclonal antibodies to IL-13 |
Sep. 8, 2009 |
| 7578999 |
Antibodies specific for sclerostin |
Aug. 25, 2009 |
| 7579446 |
Binding molecules capable of neutralizing rabies virus and uses thereof |
Aug. 25, 2009 |
| 7566450 |
Humanized anti-CCR2 antibodies and methods of use therefor |
Jul. 28, 2009 |
| 7566772 |
Antibodies against interleukin-1.beta. |
Jul. 28, 2009 |
| 7563440 |
Plasmodium falciparum antigens inducing protective antibodies |
Jul. 21, 2009 |
| 7563874 |
Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
Jul. 21, 2009 |
| RE40831 |
Human monoclonal antibodies to the hepatitis B surface antigen |
Jul. 7, 2009 |
| 7553485 |
Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof |
Jun. 30, 2009 |
| 7553486 |
Anti-VEGF treatment for radiation-induced vasculopathy |
Jun. 30, 2009 |
| 7550568 |
Monoclonal antibodies to human high molecular weight-melanoma associated antigen |
Jun. 23, 2009 |
| 7541031 |
Methods for treating rheumatoid arthritis using human antibodies that bind human TNF.alpha. |
Jun. 2, 2009 |
| 7534427 |
Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins |
May. 19, 2009 |
| 7531168 |
Method for downmodulating immune response in type I diabetes |
May. 12, 2009 |
| 7531169 |
High affinity anti-human IgE antibodies |
May. 12, 2009 |
| 7531633 |
Staphylococcus antibodies |
May. 12, 2009 |
| 7527790 |
Methods of reducing bone absorption comprising administering an antibody that binds OBM |
May. 5, 2009 |
| 7524496 |
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
Apr. 28, 2009 |
| 7524497 |
Antibodies to PRO 1120 polypeptide |
Apr. 28, 2009 |
| 7524501 |
Methods of treating an injury to, or disorder of, the eye involving photoreceptor proliferation by administering VEGF2 antibodies |
Apr. 28, 2009 |
| 7521051 |
Methods of upmodulating adaptive immune response using anti-PD-1 antibodies |
Apr. 21, 2009 |
| 7521046 |
Antibody immunization therapy for treatment of atherosclerosis |
Apr. 21, 2009 |
| 7521050 |
Human antibodies that bind human TNF.alpha. |
Apr. 21, 2009 |
| 7517524 |
Immunointeractive molecules |
Apr. 14, 2009 |
| 7514080 |
Drug conjugate composition |
Apr. 7, 2009 |
| 7507408 |
Anti hepatitis C virus antibody and uses thereof |
Mar. 24, 2009 |
| 7504105 |
Treatment using antibodies to cytokine receptor common gamma chain like |
Mar. 17, 2009 |
| 7501247 |
Method of treating skin inflammation |
Mar. 10, 2009 |
| 7501120 |
Drug conjugate composition |
Mar. 10, 2009 |
| 7498030 |
Treatment with anti-ErbB2 antibodies and anti-hormonal compounds |
Mar. 3, 2009 |
|
|
|
